EA201291042A1 - Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида - Google Patents

Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида

Info

Publication number
EA201291042A1
EA201291042A1 EA201291042A EA201291042A EA201291042A1 EA 201291042 A1 EA201291042 A1 EA 201291042A1 EA 201291042 A EA201291042 A EA 201291042A EA 201291042 A EA201291042 A EA 201291042A EA 201291042 A1 EA201291042 A1 EA 201291042A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nucleoside
combination
uclus
macrocyclic
macrocyclic inhibitor
Prior art date
Application number
EA201291042A
Other languages
English (en)
Inventor
Цзе-И Линь
Оливер Ленц
Пьер Жан-Мари Бернар Рабуассон
Original Assignee
Янссен Фармасьютикалз, Инк.
Медивир Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармасьютикалз, Инк., Медивир Аб filed Critical Янссен Фармасьютикалз, Инк.
Publication of EA201291042A1 publication Critical patent/EA201291042A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Настоящее изобретение относится к комбинации макроциклического ингибитора протеазы HCV, макроциклического ненуклеозидного ингибитора полимеразы HCV и нуклеозидного ингибитора полимеразы HCV.
EA201291042A 2010-04-13 2011-04-13 Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида EA201291042A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10159825 2010-04-13
PCT/EP2011/055836 WO2011128378A1 (en) 2010-04-13 2011-04-13 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside

Publications (1)

Publication Number Publication Date
EA201291042A1 true EA201291042A1 (ru) 2013-03-29

Family

ID=42237337

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201291042A EA201291042A1 (ru) 2010-04-13 2011-04-13 Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида

Country Status (14)

Country Link
US (1) US20130028865A1 (ru)
EP (1) EP2558091A1 (ru)
JP (1) JP5989635B2 (ru)
KR (1) KR20130057990A (ru)
CN (1) CN102844028B (ru)
AU (1) AU2011239974B2 (ru)
BR (1) BR112012026016A2 (ru)
CA (1) CA2796243A1 (ru)
EA (1) EA201291042A1 (ru)
HK (1) HK1180222A1 (ru)
MX (1) MX2012011963A (ru)
NZ (1) NZ602552A (ru)
SG (2) SG10201506652QA (ru)
WO (1) WO2011128378A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
TWI454476B (zh) 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
RU2015111491A (ru) * 2012-08-31 2016-10-20 Янссен Фармасьютикалз, Инк. Комбинация макроциклического ингибитора протеазы hcv, ненуклеозидного ингибитора hcv и ритонавира

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005073195A2 (en) 2004-01-30 2005-08-11 Medivir Ab Hcv ns-3 serine protease inhibitors
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
ES2392948T3 (es) 2006-10-10 2012-12-17 Janssen Products, L.P. Intermedio para inhibidores nucleosídicos de VHC
TWI454476B (zh) * 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
TW201023858A (en) * 2008-09-18 2010-07-01 Ortho Mcneil Janssen Pharm Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
AR077125A1 (es) * 2009-06-23 2011-08-03 Gilead Sciences Inc Combinaciones farmaceuticas utiles para tratar el vhc

Also Published As

Publication number Publication date
SG10201506652QA (en) 2015-10-29
HK1180222A1 (zh) 2013-10-18
EP2558091A1 (en) 2013-02-20
MX2012011963A (es) 2012-12-17
JP2013523866A (ja) 2013-06-17
KR20130057990A (ko) 2013-06-03
SG184524A1 (en) 2012-11-29
AU2011239974A1 (en) 2012-10-25
NZ602552A (en) 2014-09-26
AU2011239974B2 (en) 2015-12-03
BR112012026016A2 (pt) 2016-06-07
CN102844028A (zh) 2012-12-26
WO2011128378A1 (en) 2011-10-20
US20130028865A1 (en) 2013-01-31
JP5989635B2 (ja) 2016-09-07
CN102844028B (zh) 2016-04-06
CA2796243A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
EA201590534A1 (ru) Новые бициклические производные
UY34851A (es) Inhibidores macrocíclicos de virus flaviviridae
EA201101620A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
UA107822C2 (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
MX371497B (es) Composiciones y metodos que comprenden una variante de enzima lipolitica.
EA201270423A1 (ru) Ингибиторы протеазы hcv
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
EA201270149A1 (ru) Ингибиторы bace
IN2014DN09346A (ru)
TR201901382T4 (tr) Serin proteaz varyantlarını içeren bileşimler ve yöntemler.
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
MX2012006549A (es) Composiciones y metodos que comprenden variantes de proteasa.
BRPI1008684A2 (pt) queimador de gás.
ITRM20100277A1 (it) Carcassa di turbina.
EP2632908A4 (en) SULFONAMIDE AS AN HIV PROTEASE INHIBITOR
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
UY34465A (es) ?inhibidor de alfa1-proteinasa para demorar el comienzo o progresión de exacerbaciones pulmonares?.
HK1204433A1 (en) Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith hcv ns5a
BR112013010836A2 (pt) inibidores específicos de ns3 protease de hcv
EA201291042A1 (ru) Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида
UA111663C2 (uk) Газопродувний елемент і співвіднесений газопідвідний трубопровід
UY34099A (es) ?composición de agentes de coalescencia?.
WO2014033668A3 (en) Combination of a macrocyclic protease inhibitor of hcv, a non-nucleoside hcv inhibitor and ritonavir
FR2987092B1 (fr) Ensemble de reducteurs.